Partner/Owner since 1994
Representative before the EPO

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

We have observed 2 EP applications Peter Klusmann has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP15171991

GLYX FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE, AIDS DEMENTIA, PARKINSON'S DISEASE OR HUNTINGTON'S DISEASE

IPC classification:
A61K 38/10, A61P 25/22, A61P 25/24
Applicant:
Northwestern University
Agent:
Peter Klusmann, Hoffmann Eitle PartmbB
Agent:
Sarah Jane Lau, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP14789369

STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES

IPC classification:
A61L 27/20, A61L 27/50
Applicant:
Allergan Industrie SAS
Agent:
Peter Klusmann, Hoffmann Eitle PartmbB
Status:
Request for examination was made

Please Sign in to use this feature